Clinical Trial

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Name: CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL — clinical trial record (NCT07397832)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Single-Arm, Open-Label, Multicenter Phase II Trial of CRP Regimen (Chidamide, Rituximab, Polatuzumab Vedotin) in Treating Elderly Patients with Previously Untreated Double-Positive Diffuse Large B-Cell Lymphoma

Trial Details

NCT Number	NCT07397832
Lead Sponsor	Tianjin Medical University Cancer Institute and Hospital
Conditions	Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment	58 participants
Start Date	2026-02-03
Primary Completion	2028-07-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-29